However, knockdown experiments for IRX1 and IRX3 excluded FLI1 deregulation (Figure 6A,B), demonstrating functional differences in downstream activities of NKL and TALE homeo-oncogenes in AML. The gene discussed is GLIS2; the disease is acute myeloid leukemia.